Sort
21,453 grants matching “tuberculosis”
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents
$7,381,267Herbert W Virgin · Ut Southwestern Medical Center · U19 · FY2022 · AI
Clinical Research Products Management Center (CRPMC)
$7,369,967Putta Neeraja · Fisher Bioservices, Inc. · N01 · FY2019 · AI
SDMC - IMPAACT Leadership Group
$7,359,781David Eric Shapiro · Harvard School Of Public Health · UM1 · FY2016 · AI
HOST-DIRECTED APPROACHES TO TARGET GRANULOMA PATHWAYS FOR TREATMENT SHORTENING IN TUBERCULOSIS
$7,352,643The Global Alliance For Tb Drug Development Inc · · FY2024 · Defense Health Agency
TUBERCULOSIS ELIMINATION AND LABORATORY
$7,324,037Sarah Royce · California State Health/Human Srvs Agcy · U52 · FY2006 · PS
Tulane National Primate Research Center
$7,308,462Benjamin Paul Sachs · Tulane University Of Louisiana · P51 · FY2008 · RR
TUBERCULOSIS ELIMINATION AND LABORATORY
$7,217,383James D Cobb · Florida State Department Of Health · U52 · FY2006 · PS
Tri-Institutional TB Research Unit: Persistence and Latency
$7,215,105Carl F Nathan · Weill Medical Coll Of Cornell Univ · U19 · FY2016 · AI
PS05-003 TUBERCULOSIS ELIMINATION AND LABORATORY
$7,209,712Russell W Eggert · Florida State Department Of Health · U52 · FY2008 · PS
Preclinical Design and Clinical Translation of TB Regimens (PReDicTR) Consortium
$7,200,000Radojka Savic · University Of California, San Francisco · UM1 · FY2025 · AI
Preclinical Design and Clinical Translation of TB Regimens (PReDicTR) Consortium
$7,199,999Radojka Savic · University Of California, San Francisco · UM1 · FY2024 · AI
Tri-Institutional TB Research Unit: Persistence and Latency
$7,165,182Carl F Nathan · Weill Medical Coll Of Cornell Univ · U19 · FY2015 · AI
Clinical Research Products Management Center (CRPMC)
$7,162,001Putta Neeraja · Fisher Bioservices, Inc. · N01 · FY2018 · AI
PS05-003 TUBERCULOSIS ELIMINATION AND LABORATORY
$7,114,895Russell W Eggert · Florida State Department Of Health · U52 · FY2007 · PS
TUBERCULOSIS ELIMINATION AND LABORATORY
$7,086,697Sarah Royce · California State Health/Human Srvs Agcy · U52 · FY2007 · PS
TUBERCULOSIS ELIMINATION AND LABORATORY
$6,991,936Susan Penfield · Texas State Department Of Health Srvs · U52 · FY2008 · PS
Tri-Institutional TB Research Unit: Persistence and Latency
$6,990,368Carl F Nathan · Weill Medical Coll Of Cornell Univ · U19 · FY2017 · AI
UZ-UCSF CTU
$6,980,494Zvavahera Mike Chirenje · University Of California, San Francisco · UM1 · FY2014 · AI
Accelerator for the rapid development of countermeasures targeting drug resistant fungal pathogens
$6,977,446Arturo Casadevall · Johns Hopkins University · U19 · FY2025 · AI
Laboratory Center, AIDS Clinical Trials Group (ACTG); LC 2 / 3
$6,969,759Robert W. Coombs · Brigham And Women'S Hospital · UM1 · FY2015 · AI
Clinical Research Products Management Center (CRPMC)
$6,965,269Putta Neeraja · Fisher Bioservices, Inc. · N01 · FY2017 · AI
Laboratory Center, AIDS Clinical Trials Group (ACTG); LC 2 / 3
$6,927,620Grace M. Aldrovandi · University Of California Los Angeles · UM1 · FY2019 · AI
Center to develop innovative therapeutics to multidrug resistant high-threat bacterial agents
$6,880,060David S Perlin · Hackensack University Medical Center · U19 · FY2019 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$6,824,595Susan Penfield · Texas State Department Of Health Srvs · U52 · FY2009 · PS
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
$6,820,430Mark Joseph Mulligan · New York University School Of Medicine · UM1 · FY2021 · AI